Absci Corp (ABSI) concluded trading on Wednesday at a closing price of $2.76, with 4.17 million shares of worth about $11.51 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -5.48% during that period and on June 25, 2025 the price saw a loss of about -1.78%. Currently the company’s common shares owned by public are about 127.54M shares, out of which, 111.47M shares are available for trading.
Stock saw a price change of 1.85% in past 5 days and over the past one month there was a price change of 3.76%. Year-to-date (YTD), ABSI shares are showing a performance of -8.61% which increased to 5.34% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $2.01 but also hit the highest price of $6.33 during that period. The average intraday trading volume for Absci Corp shares is 3.05 million. The stock is currently trading -2.11% below its 20-day simple moving average (SMA20), while that difference is down -4.55% for SMA50 and it goes to -18.66% lower than SMA200.
Absci Corp (NASDAQ: ABSI) currently have 127.54M outstanding shares and institutions hold larger chunk of about 66.39% of that.
The stock has a current market capitalization of $352.06M and its 3Y-monthly beta is at 2.07. It has posted earnings per share of -$0.93 in the same period. It has Quick Ratio of 5.72 while making debt-to-equity ratio of 0.04. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ABSI, volatility over the week remained 1.80% while standing at 2.80% over the month.
Stock’s fiscal year EPS is expected to rise by 7.58% while it is estimated to increase by 20.11% in next year. EPS is likely to grow at an annualized rate of 3.62% for next 5-years, compared to annual growth of -29.30% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Needham on January 22, 2025 offering a Buy rating for the stock and assigned a target price of $9 to it. Coverage by Guggenheim stated Absci Corp (ABSI) stock as a Buy in their note to investors on October 02, 2024, suggesting a price target of $10 for the stock. On July 03, 2024, Morgan Stanley Initiated their recommendations, while on March 14, 2024, Scotiabank Initiated their ratings for the stock with a price target of $13. Stock get an Overweight rating from KeyBanc Capital Markets on December 05, 2023.